Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/1989
08/30/1989EP0329778A1 Molecular decoyants and methods of use thereof
08/30/1989EP0329761A1 Hiv-1-related polypeptides, diagnostic systems and assay methods
08/30/1989EP0329699A1 Immunometric assay for the detection of human chorionic gonadotropin
08/30/1989EP0247074B1 De-(acetylglucosaminyl)-di(dehydro)-deoxy teicoplanin derivatives
08/29/1989US4861710 Recombinant DNA clone encoding laminin receptor
08/29/1989US4861588 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
08/24/1989WO1989007646A1 T cell activation markers
08/24/1989WO1989007609A1 Homoarginine-based peptides as platelet aggregation inhibitors
08/24/1989WO1989007451A1 Reduced size lhrh analogs
08/24/1989WO1989007450A1 Lhrh analogs
08/24/1989WO1989007448A1 Use of synthetic peptides to generate and manipulate cellular immunity
08/24/1989WO1989006974A3 T-cell epitope as carriers molecule for conjugate vaccines
08/23/1989EP0329363A1 T cell activation markers
08/23/1989EP0329127A2 Novel, signal peptides capable of functioning in yeasts and secretory expression of heterologous proteins using same
08/23/1989EP0328634A1 Pharmaceutical compositions for the treatment of psoriasis
08/22/1989US4859753 Branched lipopeptide polymers forming thermotropic and lyotropic liquid crystals, their applications and corresponding monomers
08/22/1989CA1258750A1 Renin inhibitors containing 2-substituted statine
08/22/1989CA1258748A1 Renin inhibitory peptides
08/16/1989EP0328403A2 Synthetic peptides related to the HIV-GP120-env-protein, and their use
08/16/1989EP0328090A2 LHRH analogs
08/16/1989EP0328089A2 Reduced size LHRH analogs
08/16/1989EP0327744A1 Oxytocin and vasopressin antagonists
08/10/1989WO1989007112A1 A synthetic antigen evoking anti-hiv response
08/10/1989WO1989007111A1 Polypeptide compounds having growth hormone releasing activity
08/10/1989WO1989007110A1 Polypeptide compounds having growth hormone releasing activity
08/10/1989WO1989006974A2 T-cell epitope as carriers molecule for conjugate vaccines
08/09/1989EP0327334A2 Phospholipase A2-inhibiting peptides
08/09/1989EP0326873A2 Teicoplanin hydrazides
08/09/1989CN1034581A Antigen-antibody conjugate
08/08/1989US4855407 Solid phase process for synthesizing peptides
08/08/1989US4855406 Oncogene-related peptides
08/08/1989CA1258229A1 Amphipathic peptides
08/02/1989EP0326490A2 Synthetic peptides and mixtures thereof for detecting HIV antibodies
08/02/1989EP0325639A1 Fibrin-binding compound and method
08/02/1989EP0185715B1 Process for preparing antibiotic l 17392 (deglucoteicoplanin)
08/01/1989CA1258150A1 GONADOLIBERIN DERIVATIVES CONTAINING A .beta.-ASPARTYL GROUP, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
07/1989
07/27/1989WO1989006657A1 Pulmonary surfactant protein and related polypeptide
07/27/1989DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions
07/27/1989DE3843054A1 Neue kristallform von cyclosporin, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese kristallform sowie ihre anwendung New crystal form of cyclosporin, processes for their preparation, pharmaceutical compositions containing said crystalline form as well as their use
07/26/1989EP0325044A2 Pharmacologically active cyclic peptide
07/26/1989CN1034208A Process for the prepn. of peptide structures and immunogens containing them useful in the control of fertility
07/25/1989US4851509 Immunostimulant oligopeptides
07/25/1989US4851386 Method of treating precocious puberty
07/25/1989US4851385 Luteinizing hormone releasing hormone
07/25/1989US4851341 Forming protein-monoclonal antibody complex, isolation, dissociating
07/25/1989CA1257950A1 Therapeutic lhrh analogs
07/19/1989EP0324625A1 Antigen antibody conjugate
07/19/1989EP0324270A1 Biologically active peptides
07/18/1989CA1257540A1 Peptide antibodies and their use in detecting oncogene products
07/13/1989WO1989006242A1 Antibodies to a4 amyloid peptide
07/13/1989WO1989006241A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes
07/13/1989WO1989006240A1 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
07/13/1989WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
07/13/1989WO1989006135A1 Treatment of type 2 diabetes mellitus
07/12/1989EP0323769A1 Peptide structures, immunogens containing them, and their use in the control of fertility
07/12/1989EP0323740A2 Linear analogs of atrial natriuretic peptides
07/11/1989US4847080 Genetic engineering
07/05/1989EP0323424A2 Peptide corresponding to HIV-env 583-599, and analogs thereof and applications of the peptides
07/05/1989EP0322990A1 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
07/04/1989US4844895 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
06/1989
06/29/1989WO1989005654A1 Linear analogs of atrial natriuretic peptides
06/28/1989EP0322348A2 Acidically non-stable anchoring groups for solid-phase peptide amide synthesis
06/28/1989EP0321696A2 Novel hydrogenated derivatives of antibiotic A/16686
06/21/1989EP0321094A2 Treatment of factor VIII inhibitors
06/21/1989EP0320967A2 ANF derivatives with novel bridging
06/21/1989EP0320840A2 Peptides, method for their preparation, antibodies to it, and their use in blocking the PAI-1 activity of human blood
06/20/1989CA1256249A1 Diagnostic preparations and their use
06/15/1989WO1989005353A1 Common acute lymphoblastic leukemia antigen
06/15/1989WO1989005352A1 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF
06/15/1989WO1989005150A1 Conformationally stabilized cell adhesion peptides
06/15/1989WO1989005147A1 New anti-inflammatory agents
06/13/1989US4839465 Substance p antagonist, hypotensive agent, analgesics
06/13/1989US4839344 Polypeptide compounds having growth hormone releasing activity
06/13/1989US4839288 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
06/13/1989EP0246307A4 Cys codon-modified dna.
06/13/1989CA1255850A1 Peptides with disulfide bridges and method
06/13/1989CA1255586A1 Method of determining mimotopes
06/07/1989EP0319315A2 The von Willebrand factor binding domain of factor VIII
06/07/1989EP0318680A2 Novel antibiotic compounds named A/16686 Factors A'1, A'2 and A'3
06/01/1989WO1989004669A1 Nanbv diagnostics and vaccines
06/01/1989WO1989004667A1 Agent for prophylaxis and treatment of virally infected diseases
05/1989
05/31/1989EP0318216A1 NANBV diagnostics and vaccines
05/31/1989EP0317595A1 Hiv polypeptide, its preparation and use in detection of hiv antibodies
05/30/1989US4835254 Process for reducing methionine sulfoxide residues in peptides or proteins
05/30/1989US4835253 Low molecular weight kininogen analogs
05/30/1989CA1254896A1 Fluorescent indicator dyes for calcium ions
05/24/1989EP0317279A2 Peptides for use in the purification of factor VIII
05/24/1989EP0317278A2 Proteolytic fragments and synthetic peptides that block the binding of von Willebrand factor to the platelet membrane glycoprotein Ib
05/24/1989EP0316965A2 Enzyme inhibitors
05/24/1989EP0316769A2 Disulfide bridged cyclic peptides containing a cgridri sequence useful in control of hypertension
05/24/1989EP0316725A2 Process for the enzymatic synthetis of peptides containing at least one non-proteic aminoacid, and peptides derived from this synthesis
05/24/1989EP0316712A2 22-Dechloroteicoplanins
05/24/1989EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER
05/23/1989US4833072 Polypeptides, aids
05/23/1989US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
05/23/1989CA1254700A1 Process for preparing biologically active heptapeptides
05/18/1989WO1989004491A1 Urinary assay for measuring bone resorption
05/18/1989WO1989004486A1 Diagnostic methods and systems for quantifying apo ai
05/18/1989WO1989004209A1 Emulsifiers
05/17/1989EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them
1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 423